Tarsus Pharmaceuticals Statistics
NASDAQ: TARSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
71.29-2.32 (-3.15%)
Market open · Delayed 15 min · as of Oct 8, 12:51 PM ET
Tarsus Pharmaceuticals by the numbers
Tarsus Pharmaceuticals has a market capitalization of $3.34 billion based on 46.79M shares outstanding. With trailing EPS of $-1.08, Tarsus Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.8% below its 50-day average and 4.1% above its 200-day average.
Average daily trading volume is 894.35K shares, or about $63.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TARS valuation vs. peer median
| Metric | TARS | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.34B | $2.39B | +40% |
| Avg. volume | 894.35K | 2.51M | -64% |
Peer median across 8 companies: RLAY, DNLI, ADPT, BEAM, ADMA, BCRX, VCEL, RXRX.
Valuation
- Market cap
- $3.34B
- Price / sales (latest FY)
- 7.39
- EPS (TTM)
- $-1.08
- Shares outstanding
- 46.79M
Price and trading
- Previous close
- 73.61
- Open
- 73.07
- Day range
- 70.80 – 74.52
- 52-week range
- 53.89 – 91.53
- 52-week change
- +7.59%
- Beta
- —
- Volume
- 150.63K
- Average volume
- 894.35K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 3.34B
- Forward Pe
- -198.03
- Eps
- -1.08
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 91.53
- Week52 Low
- 53.89
- Avg Volume
- 894.35K
- Shares Outstanding
- 46.79M
- Ma50
- 73.31
- Ma200
- 68.48
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -22.11%
- Pct From52w Low
- 32.29%